Our Wegovy and Mounjaro price changes: what you need to know

Simon Edward • 24 September 2025

We've reviewed our prices following market changes. Now, some will pay less and some more. See how it affects you and what your options are.

We've reviewed our prices following market changes. Now, some will pay less and some more. See how it affects you and what your options are.

You might have heard about the recent Mounjaro price increases. On 1 September 2025, Mounjaro's manufacturer, Eli Lilly, raised the wholesale price of Mounjaro in the UK. This price hike has led many providers to raise prices for customers, too.


At SemaPen, we froze the price of Mounjaro and absorbed most of the cost instead. Throughout September, new customers have paid £159 for a starting (2.5mg) dose.


We kept the price at this level because we wanted to give you plenty of time to choose what to do next. After all, it's not fair to rush you when you're making a decision that could affect your health and weight.


However, the offer couldn't last forever. We've reviewed our pricing again and, like nearly all UK suppliers, have taken the difficult decision to change our prices in line with market conditions.


What are the new prices?


As of 1st October, our new prices are as follows:


  • Mounjaro costs £225 for the starting dose (0.25mg).
  • Wegovy costs £189 for the starting dose (2.5mg).


As before, the price you pay changes as you step up your dose. Here's how the new prices look, month by month:

Mounjaro


Month 1 (2.5mg):  £225

Month 2 (5mg):  £225

Month 3 (7.5mg):  £299

Month 4 (10mg):  £299

Month 5 onwards (12.5mg): £349

Wegovy


Month 1 (0.25mg): £189

Month 2 (0.5mg):  £189

Month 3 (1mg):  £189

Month 4 (1.7mg):  £289

Month 5 onwards (2.4mg):  £289

That means 12 months of treatment with Mounjaro now costs £3,840. Previously, it cost £3,290.


Why have Wegovy prices increased, too?


We've increased the starting price of Wegovy from £129 to £189.


However, we've also tweaked the price for each dose that follows. With our new, simplified pricing, long-term treatment with Wegovy is actually cheaper than it was before


Previously, 12 months of Wegovy cost you £3,238. Now, it costs £3,168.


That's a saving of £70 on the old price – and £672 less than 12 months of Mounjaro.


What are my options?


We know it's frustrating when our prices change. But the important thing is that you're free to make the best decision for you.


If you subscribe to our Mounjaro programme, you can choose to:


  • Carry on with the new pricing: we'll send your next dose as normal at the new price.
  • Switch to Wegovy: talk to your SemaPen team and we'll arrange a fast-track medication review. If Wegovy is suitable for you, we'll switch you to Wegovy and you'll pay Wegovy prices from your next dose.
  • Cancel your subscription: while we'd love you to continue your weight loss journey with SemaPen, you're free to cancel your subscription at any time.*


The same is true if you're a Wegovy subscriber. But don't forget that Wegovy now costs less in the long run compared to the old pricing.


Which medication offers the best value for me?


Remember that Wegovy yields an average weight loss of around 15%.¹ With Mounjaro, it's approximately 21%.²


That extra 6% of weight loss might be more cost-effective for some people than others. As an example:


  • If you started at 150kg, you could expect to lose 7kg more with Mounjaro. It would cost you around £17 more per kilogramme.
  • If you started at 90kg, you could expect to lose 4kg more with Mounjaro. It would cost you around £31 more per kilogramme.


Want to see what you could expect to lose – and how much you'd pay per kilogramme for each drug? Try our Wegovy vs Mounjaro cost and weight loss calculator below.

Drag the slider to your start weight
After 12 months

If you have any questions about our price changes, please don't hesitate to get in touch with the SemaPen team.


Sources and small print


1. Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183


2. Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" The New England Journal of Medicine, 387(3) https://doi.org/10.1056/NEJMoa2206038


* An admin fee may apply for early cancellation. See our terms and conditions.

  • Average 15–21% weight loss
  • Trusted programmes built by UK experts
  • Personalised advice and support
  • Smart weight loss app to track progress and learn positive habits

Your journey starts in the app

Unlock tailored support, weight tracking and more.

1

Download the free app

2

Take your digital consultation

3

Start your programme

Download the app
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal
by Simon Edward 23 February 2026
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.
There's a strong link between obesity and hypertension (high blood pressure). But what causes it?
by Simon Edward 20 February 2026
There's a strong link between obesity and hypertension (high blood pressure). But what causes it? And what can you do to lower your risk?
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything
by Simon Edward 16 February 2026
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything and still lose weight. Learn what dieticians recommend.
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts
by Simon Edward 13 February 2026
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts about this US-made injectable medication.
Are you considering using Wegovy for weight loss? Read our beginner's guide
by Simon Edward 9 February 2026
Are you considering using Wegovy for weight loss? Read our beginner's guide to get the key information you need in one place.
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why –
by Simon Edward 6 February 2026
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why – and what to do instead.
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity
by Simon Edward 2 February 2026
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity and type 2 diabetes. Let's explore their findings in more detail.
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks
by Simon Edward 31 January 2026
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks in people with chronic kidney disease.
Excess weight can increase the risk of heart problems. Could Mounjaro injections help?
by Simon Edward 31 January 2026
Excess weight can increase the risk of heart problems. Could Mounjaro injections help? Explore the key findings of the SUMMIT clinical trial.
Weight loss diets have been around since at least the mid-1800s.
by Simon Edward 31 January 2026
Weight loss diets have been around since at least the mid-1800s. But does this old-timey advice stand up today? Let's find out.
More posts